Lyka Labs · NSE: LYKALABS · BSE: 500259
Q1 FY21 results · Apr–Jun 2020
Lyka Labs reported revenue from operations of ₹17.72 crore (up 23.4% from Q1 FY20) and net loss of ₹4.09 crore for Q1 FY21 (Apr–Jun 2020), on a consolidated basis.
| Item | Q1 FY21 | Q1 FY20 | YoY | Q4 FY20 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 17.72 | 14.36 | +23.4% | 15.07 | +17.6% |
| Other income | 0.36 | 0.23 | +55.3% | 1.17 | −69.3% |
| Total income | 18.08 | 14.60 | +23.9% | 16.24 | +11.3% |
| Profit before tax | (4.14) | (4.40) | Loss narrowed | (12.88) | Loss narrowed |
| Net profit for the period | (4.09) | (3.17) | Loss widened | (13.93) | Loss narrowed |
| EPS, basic (₹) | (1.64) | (1.13) | Loss widened | (5.67) | Loss narrowed |
| Net margin (%) | -23.1 | -22.0 | -92.4 |
| Item | Q1 FY21 | Q1 FY20 | YoY | Q4 FY20 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 10.50 | 6.74 | +55.7% | 8.57 | +22.5% |
| Other income | 0.47 | 0.19 | +153.6% | 0.80 | −41.5% |
| Total income | 10.97 | 6.93 | +58.4% | 9.38 | +17.0% |
| Profit before tax | (5.78) | (2.38) | Loss widened | (8.17) | Loss narrowed |
| Net profit for the period | (5.72) | (2.41) | Loss widened | (9.12) | Loss narrowed |
| EPS, basic (₹) | (2.00) | (0.87) | Loss widened | (3.21) | Loss narrowed |
| Net margin (%) | -54.5 | -35.8 | -106.4 |
Consolidated
- Filed with BSE
- 10 Aug 2020, 10:52 IST
- Board meeting
- 07 Aug 2020
- Period
- 01 Apr 2020 to 30 Jun 2020
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 10 Aug 2020, 10:52 IST
- Board meeting
- 07 Aug 2020
- Period
- 01 Apr 2020 to 30 Jun 2020
- Review status
- Unaudited
- Source
- XBRL filing on BSE